Kenmed Pharma Private Limited
Founded in 2021 and headquartered in Rajasthan, India.
2021 | Jaipur, Rajasthan (India) | Active
Kenmed Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
About Kenmed Pharma
Kenmed Pharma Private Limited (KPPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 May 2021 (Three years and nine months 17 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Harish Gupta, Ashish Gupta, Laxman Saini, and One other member serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909RJ2021PTC074915
- Company No.
074915
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 May 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Trading
Other Industry
Who are the key members and board of directors at Kenmed Pharma?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Harish Gupta  | Director | 12-May-2021 | Current |
| Ashish Gupta | Director | 12-May-2021 | Current |
| Laxman Saini | Director | 12-May-2021 | Current |
| Mahesh Pareek | Director | 01-Apr-2022 | Current |
Financial Performance of Kenmed Pharma.
Enhance accessibility to Kenmed Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kenmed Pharma?
Unlock access to Kenmed Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Kenmed Pharma?
Kenmed Pharma has a workforce of 13 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kenmed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kenmed Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.